PortfoliosLab logo
NVO vs. POST
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between NVO and POST is 0.38, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Performance

NVO vs. POST - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Novo Nordisk A/S (NVO) and Post Holdings, Inc. (POST). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Sharpe Ratio

NVO:

-1.05

POST:

0.38

Sortino Ratio

NVO:

-1.51

POST:

0.55

Omega Ratio

NVO:

0.81

POST:

1.06

Calmar Ratio

NVO:

-0.76

POST:

0.39

Martin Ratio

NVO:

-1.34

POST:

0.89

Ulcer Index

NVO:

34.06%

POST:

5.82%

Daily Std Dev

NVO:

43.26%

POST:

18.86%

Max Drawdown

NVO:

-71.29%

POST:

-47.37%

Current Drawdown

NVO:

-50.36%

POST:

-8.39%

Fundamentals

Market Cap

NVO:

$303.58B

POST:

$6.12B

EPS

NVO:

$3.57

POST:

$5.70

PE Ratio

NVO:

19.46

POST:

19.26

PEG Ratio

NVO:

1.26

POST:

1.19

PS Ratio

NVO:

1.00

POST:

0.78

PB Ratio

NVO:

14.65

POST:

1.60

Total Revenue (TTM)

NVO:

$303.14B

POST:

$7.88B

Gross Profit (TTM)

NVO:

$255.65B

POST:

$2.29B

EBITDA (TTM)

NVO:

$154.08B

POST:

$1.28B

Returns By Period

In the year-to-date period, NVO achieves a -15.54% return, which is significantly lower than POST's -3.38% return. Over the past 10 years, NVO has underperformed POST with an annualized return of 11.78%, while POST has yielded a comparatively higher 14.49% annualized return.


NVO

YTD

-15.54%

1M

7.60%

6M

-31.97%

1Y

-45.09%

3Y*

10.66%

5Y*

18.68%

10Y*

11.78%

POST

YTD

-3.38%

1M

-2.28%

6M

-8.21%

1Y

7.20%

3Y*

10.38%

5Y*

14.19%

10Y*

14.49%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Novo Nordisk A/S

Post Holdings, Inc.

Go deeper with the Portfolio Analysis tool — backtest performance, assess risk, compare to benchmarks, and more

Risk-Adjusted Performance

NVO vs. POST — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NVO
The Risk-Adjusted Performance Rank of NVO is 66
Overall Rank
The Sharpe Ratio Rank of NVO is 33
Sharpe Ratio Rank
The Sortino Ratio Rank of NVO is 55
Sortino Ratio Rank
The Omega Ratio Rank of NVO is 66
Omega Ratio Rank
The Calmar Ratio Rank of NVO is 66
Calmar Ratio Rank
The Martin Ratio Rank of NVO is 1111
Martin Ratio Rank

POST
The Risk-Adjusted Performance Rank of POST is 5959
Overall Rank
The Sharpe Ratio Rank of POST is 6464
Sharpe Ratio Rank
The Sortino Ratio Rank of POST is 5252
Sortino Ratio Rank
The Omega Ratio Rank of POST is 4949
Omega Ratio Rank
The Calmar Ratio Rank of POST is 6868
Calmar Ratio Rank
The Martin Ratio Rank of POST is 6262
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

NVO vs. POST - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Novo Nordisk A/S (NVO) and Post Holdings, Inc. (POST). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current NVO Sharpe Ratio is -1.05, which is lower than the POST Sharpe Ratio of 0.38. The chart below compares the historical Sharpe Ratios of NVO and POST, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading data...

Go to the full Sharpe Ratio tool to analyze any stock or portfolio. Customize time frames, set your own risk-free rate, and more

Dividends

NVO vs. POST - Dividend Comparison

NVO's dividend yield for the trailing twelve months is around 2.25%, while POST has not paid dividends to shareholders.


TTM20242023202220212020201920182017201620152014
NVO
Novo Nordisk A/S
2.25%1.68%1.00%1.20%1.34%1.86%2.14%2.47%2.12%3.93%1.31%1.96%
POST
Post Holdings, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Drawdowns

NVO vs. POST - Drawdown Comparison

The maximum NVO drawdown since its inception was -71.29%, which is greater than POST's maximum drawdown of -47.37%. Use the drawdown chart below to compare losses from any high point for NVO and POST.


Loading data...

Go to the full Drawdowns tool for more analysis options, including inflation-adjusted drawdowns, and more

Volatility

NVO vs. POST - Volatility Comparison

Novo Nordisk A/S (NVO) has a higher volatility of 13.11% compared to Post Holdings, Inc. (POST) at 4.86%. This indicates that NVO's price experiences larger fluctuations and is considered to be riskier than POST based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading data...

Financials

NVO vs. POST - Financials Comparison

This section allows you to compare key financial metrics between Novo Nordisk A/S and Post Holdings, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0020.00B40.00B60.00B80.00B20212022202320242025
78.09B
1.95B
(NVO) Total Revenue
(POST) Total Revenue
Values in USD except per share items

NVO vs. POST - Profitability Comparison

The chart below illustrates the profitability comparison between Novo Nordisk A/S and Post Holdings, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

20.0%30.0%40.0%50.0%60.0%70.0%80.0%90.0%20212022202320242025
83.5%
28.0%
(NVO) Gross Margin
(POST) Gross Margin
NVO - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Novo Nordisk A/S reported a gross profit of 65.20B and revenue of 78.09B. Therefore, the gross margin over that period was 83.5%.

POST - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Post Holdings, Inc. reported a gross profit of 545.80M and revenue of 1.95B. Therefore, the gross margin over that period was 28.0%.

NVO - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Novo Nordisk A/S reported an operating income of 38.79B and revenue of 78.09B, resulting in an operating margin of 49.7%.

POST - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Post Holdings, Inc. reported an operating income of 182.20M and revenue of 1.95B, resulting in an operating margin of 9.3%.

NVO - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Novo Nordisk A/S reported a net income of 29.03B and revenue of 78.09B, resulting in a net margin of 37.2%.

POST - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Post Holdings, Inc. reported a net income of 62.60M and revenue of 1.95B, resulting in a net margin of 3.2%.